NCT00219934|CompletedDMC
Loading search results
Sponsor study identifier
observational
399
1 country
1
Study Start
February 2002
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 2010
Actual (reported)Study Completion
November 2010
Actual (reported)Group A: Long-term follow-up is needed for subjects identified as acute or early in the course of HIV-1 infection, independent of decisions regarding therapy with highly active anti-retroviral therapy (HAART). Group B: This protocol will also be offered to subjects who were diagnosed with acute HIV-1 infection in the past and have been participating in an ADARC/Rockefeller University Hospital treatment protocol for acute HIV-1 infection, and currently have a viral load consistently less than 50 copies/ml on current treatment (Group B)
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 2010
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 2002
Date type not reportedThis date has not been verified as actual or estimated.
September 20, 2005
Actual (reported)September 22, 2005
Actual (reported)November 2010
Actual (reported)November 2010
Actual (reported)Development of AIDS or AIDS-defining conditions as per the CDC
end of study
Death due to AIDS or AIDS-defining conditions
end of study
Morbidity due to therapy
end of study
Death due to therapy
end of study
HIV-1 RNA levels
duration of the study
T-cell subsets
duration of study
acute or early in the course of HIV-1 infection, independent of decisions regarding therapy with HAART.
subjects who were diagnosed with acute HIV-1 infection in the past and have been participating in an ADARC/Rockefeller University Hospital treatment protocol for acute HIV-1 infection, and currently have a viral load consistently less than 50 copies/ml on current treatment
HAART therapy
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Subjects will be recruited from the community or from existing ADARC clinical trials. Participants will give written informed consent.
Rockefeller University Hospital
New York, New York, 10065, United States
PLASMA AND PERIPHERAL BLOOD MONONUCLEAR CELLS
Martin Markowitz, MD
Rockefeller University
399 participants (actual enrollment reported by the registry).
First Submitted
September 20, 2005
First Posted
September 22, 2005
Study Start
February 2002
Date type not reportedThis date has not been verified as actual or estimated.
VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living With HIV-1
Contact the study team to confirm eligibility.
Primary Completion
November 2010
Actual (reported)Study Completion
November 2010
Actual (reported)Last Updated
February 17, 2012
Record last verified: 2012-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: